272 related articles for article (PubMed ID: 27633385)
1. Drugs in early clinical development for the treatment of osteosarcoma.
Heymann MF; Brown HK; Heymann D
Expert Opin Investig Drugs; 2016 Nov; 25(11):1265-1280. PubMed ID: 27633385
[TBL] [Abstract][Full Text] [Related]
2. Advances in emerging drugs for osteosarcoma.
Hattinger CM; Fanelli M; Tavanti E; Vella S; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2015 Sep; 20(3):495-514. PubMed ID: 26021401
[TBL] [Abstract][Full Text] [Related]
3. An update on emerging drugs in osteosarcoma: towards tailored therapies?
Hattinger CM; Patrizio MP; Magagnoli F; Luppi S; Serra M
Expert Opin Emerg Drugs; 2019 Sep; 24(3):153-171. PubMed ID: 31401903
[No Abstract] [Full Text] [Related]
4. TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.
Guiho R; Biteau K; Heymann D; Redini F
Future Oncol; 2015; 11(3):535-42. PubMed ID: 25675131
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for high-grade osteosarcoma.
Hattinger CM; Pasello M; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2010 Dec; 15(4):615-34. PubMed ID: 20690888
[TBL] [Abstract][Full Text] [Related]
6. Advances in Osteosarcoma.
Panez-Toro I; Muñoz-García J; Vargas-Franco JW; Renodon-Cornière A; Heymann MF; Lézot F; Heymann D
Curr Osteoporos Rep; 2023 Aug; 21(4):330-343. PubMed ID: 37329384
[TBL] [Abstract][Full Text] [Related]
7. Monocytes, Macrophages, and Osteoclasts in Osteosarcoma.
Kelleher FC; O'Sullivan H
J Adolesc Young Adult Oncol; 2017 Sep; 6(3):396-405. PubMed ID: 28263668
[TBL] [Abstract][Full Text] [Related]
8. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
[TBL] [Abstract][Full Text] [Related]
10. Current and future therapeutic approaches for osteosarcoma.
Harrison DJ; Geller DS; Gill JD; Lewis VO; Gorlick R
Expert Rev Anticancer Ther; 2018 Jan; 18(1):39-50. PubMed ID: 29210294
[TBL] [Abstract][Full Text] [Related]
11. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?
Kager L; Diakos C; Bielack S
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1025-8. PubMed ID: 25882838
[TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for the treatment of bone metastasis.
Pantano F; Iuliani M; Zoccoli A; Fioramonti M; De Lisi D; Fioroni I; Ribelli G; Santoni M; Vincenzi B; Tonini G; Santini D
Expert Opin Emerg Drugs; 2015; 20(4):637-51. PubMed ID: 26113304
[TBL] [Abstract][Full Text] [Related]
13. Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.
Shaikh AB; Li F; Li M; He B; He X; Chen G; Guo B; Li D; Jiang F; Dang L; Zheng S; Liang C; Liu J; Lu C; Liu B; Lu J; Wang L; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(4):506. PubMed ID: 27058531
[TBL] [Abstract][Full Text] [Related]
14. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
15. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.
Li S; Sun W; Wang H; Zuo D; Hua Y; Cai Z
Tumour Biol; 2015 Mar; 36(3):1329-38. PubMed ID: 25666750
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma: the state of affairs dictates a change. What do we know?
Kleinerman ES; Mary V; John A
Adv Exp Med Biol; 2014; 804():vii-viii. PubMed ID: 25207354
[No Abstract] [Full Text] [Related]
17. New targets and approaches in osteosarcoma.
Gill J; Ahluwalia MK; Geller D; Gorlick R
Pharmacol Ther; 2013 Jan; 137(1):89-99. PubMed ID: 22983152
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids Active Against Osteosarcoma: A Review of the Molecular Mechanisms Involved.
Liu H; Gao Y; Dong Y; Cheng P; Chen A; Huang H
Curr Pharm Des; 2017; 23(13):1993-2001. PubMed ID: 28201973
[TBL] [Abstract][Full Text] [Related]
19. Current research progress in targeted anti-angiogenesis therapy for osteosarcoma.
Liu Y; Huang N; Liao S; Rothzerg E; Yao F; Li Y; Wood D; Xu J
Cell Prolif; 2021 Sep; 54(9):e13102. PubMed ID: 34309110
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of primary osteosarcoma in 2009].
Piperno-Neumann S
Bull Cancer; 2010 Jun; 97(6):715-21. PubMed ID: 20483711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
